Overall rank by patents
#11,418
Across all tracked assignees
USPTO PatentsView assignee record - 27 granted patents across 18 technology areas, active 2015–2018. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A47K (SANITARY EQUIPMENT NOT OTHERWISE PROVIDED FOR ; TOILET ACCESSORIES).
The verdict
SCA holds 27 US patents across 18 technology areas, rank #11,418 of 50,000 tracked assignees.
SCA Tissue France has been granted 27 US utility patents between 2015 and 2018, placing SCA Tissue France at rank #11,418 across all assignees tracked by PlainPatent. This portfolio spans 18 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.7 claims per patent with primary concentration in A47K (SANITARY EQUIPMENT NOT OTHERWISE PROVIDED FOR ; TOILET ACCESSORIES). As a Foreign Corporation, SCA Tissue France is one of the more focused assignees in the PatentsView dataset. By volume, SCA sits between Reflect Scientific Inc. (27 patents, rank #11,414) and Shennan Circuits Co., Ltd. (27 patents, rank #11,422) - the closest US assignees by grant volume. The composite Innovation Score of 34.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 27 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. SCA Tissue France's 12.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 18 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark SCA Tissue France against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Reflect Scientific Inc.
27 patents
SAFOCO, INC.
27 patents
SAKTI3, INC.
27 patents
SANDEN AUTOMOTIVE CLIMATE SYSTEMS CORPORATION
27 patents
SCIAPS, INC.
27 patents
SELLE ROYAL S.P.A.
27 patents
SHANGHAI HODE INFORMATION TECHNOLOGY CO., LTD.
27 patents
SHENNAN CIRCUITS CO., LTD.
27 patents
SCA TISSUE FRANCE
27 patents
What this shows SCA holds 27 patents at rank #11,418, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #11,418 in granted patent volume.
Other assignees with the most granted patents in SCA's primary technology class.
SCA's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
34 Top 53% higher than 47% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 7 | 25.9% |
| 2016 | 9 | 33.3% |
| 2017 | 9 | 33.3% |
| 2018 | 2 | 7.4% |
Top 15 of 18 technology areas
Overall rank by patents
#11,418
Across all tracked assignees
34.1 out of 100
How to use this portfolio
SCA's 27 grants land it in the top 53% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.